IFNA1 and systemic lupus erythematosus: This includes the distinction between signatures and scores, abbreviations for IFN subtypes and even the use of the term ‘interferonopathy’ (used to indicate either monogenic diseases, but also to refer to any polygenic RMDs in which increased IFN pathway activation was observed, especially SLE).